Elixinol Wellness Limited
ELLXF
$0.01
$0.0092.50%
OTC PK
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -789.90K | -787.40K | -990.70K | -970.10K | 336.90K |
| Total Depreciation and Amortization | 117.50K | 117.10K | 163.70K | 160.30K | 164.50K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -175.90K | -175.30K | 384.00K | 376.10K | 73.00K |
| Change in Net Operating Assets | 247.40K | 246.70K | -- | -- | -1.01M |
| Cash from Operations | -600.90K | -599.00K | -443.00K | -433.80K | -431.40K |
| Capital Expenditure | -17.10K | -17.00K | -4.20K | -4.10K | -4.90K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -38.40K | -38.30K | -- | -- | -153.50K |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -5.60K | -5.60K | -5.40K | -5.30K | 0.00 |
| Cash from Investing | -61.00K | -60.80K | -9.60K | -9.40K | -158.30K |
| Total Debt Issued | 104.00K | 104.00K | 699.00K | 699.00K | 430.50K |
| Total Debt Repaid | -105.00K | -105.00K | -47.50K | -47.50K | -434.50K |
| Issuance of Common Stock | 1.27M | 1.27M | 75.00K | 75.00K | 747.50K |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -163.50K | -163.50K | -6.00K | -6.00K | -84.50K |
| Cash from Financing | 724.90K | 722.60K | 461.60K | 452.00K | 429.40K |
| Foreign Exchange rate Adjustments | 41.40K | 41.20K | -6.10K | -6.00K | -2.30K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 104.40K | 104.00K | 2.90K | 2.80K | -162.60K |